Infliximab in the treatment of refractory posterior uveitis-Reference-Cited by-同舟云学术

Infliximab in the treatment of refractory posterior uveitis

Published:2003-07 Issue:7 Volume:110 Page:1449-1453
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Joseph Annie,Raj Dev,Dua Harminder S,Powell Pauline T,Lanyon Peter C,Powell Richard J

Publisher

Elsevier BV

Subject

Ophthalmology

Reference19 articles.

1. Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications;Nussenblatt;Invest Ophthalmol Vis Sci,1991

2. Autoimmunity and autoimmune disease of the eye;Forrester;Dev Ophthalmol,1999

3. Immunopathogenic mechanisms in intraocular inflammation;Forrester;Chem Immunol,1999

4. Immunopathology of the noninfectious posterior and intermediate uveitides;Boyd;Surv Ophthalmol,2001

5. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat;de Vos;Invest Ophthalmol Vis Sci,1994

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Biosimilar Infliximab-Dyyb in Non-Infectious Uveitis;Ocular Immunology and Inflammation;2023-08-15

2. TNF-α in Uveitis: From Bench to Clinic;Frontiers in Pharmacology;2021-11-02

3. Das Treatment Exit Options for Uveitis (TOFU) Register: Einbindung von Patienten in die Evidenzgenerierung;Das Gesundheitswesen;2021-11

4. Efficacy and Safety of Infliximab in HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy;Journal of Ophthalmic and Vision Research;2020-10-25

5. The current status of biological treatment for uveitis;Expert Review of Clinical Immunology;2020-08-01